Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

Presenter: Jurij Avramovic

October 29, 2024

Presentation TCT 2024

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

Presenter: Jurij Avramovic

October 28, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Presenter: Jurij Avramovic

February 02, 2024

$Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction$

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Presenter: Jurij Avramovic

February 02, 2024

Advertisement

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content